# US 2020/0261092 A1 · Medical device for treating esophageal atresia

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0261092 A1
- Document ID: US20200261092A1
- Status: Published application
- Kind: A1
- Application number: 16/791,824
- Filed: 2020-02-14
- Published: 2020-08-20
- Earliest claimed: 2019-02-15
- Assignees: Boston Scientific Scimed, Inc.
- Applicants: Boston Scientific Scimed, Inc.
- Inventors: MICHAEL WALSH; MARTYN G. FOLAN
- Web page: https://patentgrep.com/patent/US20200261092A1

## CPC

- A61B 17/1114: {of the digestive tract, e.g. bowels or oesophagus}
- A61B 2017/00526: {Methods of manufacturing}
- A61B 2017/00893: {pharmaceutically effective}
- A61B 2017/1132: {End-to-end connections}
- A61B 2090/3966: {Radiopaque markers visible in an X-ray image}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A medical device for treating esophageal atresia may include a woven tubular member having a first end, a second end, and a body portion extending between the first end and the second end. The first end may have a first flange extending radially outwardly from the body portion. The second end may have a second flange extending radially outwardly from the body portion. The woven tubular member may be configured to transition from an initially-deployed state toward an equilibrium state. In the initially-deployed state, the body portion may include an inner region extending from the first flange to a transition region and an outer region extending from the second flange to the transition region. The outer region may surround the inner region. The woven tubular member may be self-biased to be in the equilibrium state.

## Claims

### Claim 1

A medical device for treating esophageal atresia, comprising:
a woven tubular member having a first end, a second end, and a body portion extending between the first end and the second end;
the first end having a first flange extending radially outwardly from the body portion;
the second end having a second flange extending radially outwardly from the body portion;
wherein the woven tubular member is configured to transition from an initially-deployed state toward an equilibrium state;
wherein in the initially-deployed state, the body portion includes an inner region extending from the first flange to a transition region and an outer region extending from the second flange to the transition region;
wherein the outer region surrounds the inner region;
wherein the woven tubular member is self-biased to be in the equilibrium state.

### Claim 2 (depends on 1)

The medical device of claim 1, wherein an axial length of the inner region decreases and an axial length of the outer region increases as the woven tubular member transitions from the initially-deployed state toward the equilibrium state.

### Claim 3 (depends on 1)

The medical device of claim 1, wherein in the equilibrium state, the first flange is disposed within the outer region.

### Claim 4 (depends on 1)

The medical device of claim 1, further comprising a covering disposed on at least a portion of the woven tubular member.

### Claim 5 (depends on 4)

The medical device of claim 4, wherein at least one of the first flange and the second flange includes the covering.

### Claim 6 (depends on 4)

The medical device of claim 4, wherein the covering at least partially encapsulates the woven tubular member.

### Claim 7 (depends on 1)

The medical device of claim 1, wherein an outer diameter of the inner region increases as its axial length decreases.

### Claim 8 (depends on 1)

The medical device of claim 1, wherein a portion of the body portion is everted from the inner region to the outer region as the woven tubular member transitions from the initially-deployed state toward the equilibrium state.

### Claim 9

A method of manufacturing a medical device for treating esophageal atresia, comprising:
forming a woven tubular member having a first end, a second end, and a body portion extending between the first end and the second end, the woven tubular member including: a first flange extending radially outwardly from the body portion at the first end, and a second flange extending radially outwardly from the body portion at the second end;
disposing a tubular spacer around the body portion;
everting the second end back over the tubular spacer to define an inner region of the body portion within the tubular spacer and an outer region of the body portion surrounding the tubular spacer; and
annealing the woven tubular member to define an equilibrium state in which the outer region surrounds the inner region.

### Claim 10 (depends on 9)

The method of claim 9, further comprising:
removing the tubular spacer after annealing the woven tubular member.

### Claim 11 (depends on 10)

The method of claim 10, further comprising:
disposing a covering on the body portion between the first end and the second end.

### Claim 12 (depends on 11)

The method of claim 11, wherein the covering extends over the first flange and the second flange.

### Claim 13 (depends on 9)

The method of claim 9, wherein the outer region surrounds the first flange in the equilibrium state.

### Claim 14 (depends on 9)

The method of claim 9, wherein the woven tubular member is self-biased to be in the equilibrium state after annealing the woven tubular member.

### Claim 15 (depends on 9)

The method of claim 9, further comprising:
partially annealing the woven tubular member after disposing the tubular spacer around the body portion but before everting the second end back over the tubular spacer.

### Claim 16

A medical device for treating esophageal atresia, comprising:
a woven tubular member having a first end, a second end, and a body portion extending between the first end and the second end;
the first end having a first flange extending radially outwardly from the body portion;
the second end having a second flange extending radially outwardly from the body portion; and
the body portion having an inner region extending from the first flange to a transition region and an outer region extending from the second flange to the transition region;
wherein the outer region surrounds the inner region;
wherein the woven tubular member is configured to transition from an initially-deployed state toward an equilibrium state;
wherein a portion of the body portion is everted from the inner region to the outer region as the woven tubular member transitions from the initially-deployed state toward the equilibrium state.

### Claim 17 (depends on 16)

The medical device of claim 16, wherein the first flange moves toward the second flange as the woven tubular member transitions from the initially-deployed state toward the equilibrium state.

### Claim 18 (depends on 17)

The medical device of claim 17, wherein the outer region of the woven tubular member surrounds the first flange in the equilibrium state.

### Claim 19 (depends on 18)

The medical device of claim 18, wherein an outer diameter of the inner region increases as the woven tubular member transitions from the initially-deployed state toward the equilibrium state.

### Claim 20 (depends on 19)

The medical device of claim 19, wherein in the initially-deployed state, the woven tubular member has a proximalmost extent and a distalmost extent, the second flange being positioned at a location intermediate the proximalmost extent and the distalmost extent.
